Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$5.87 USD
-0.03 (-0.51%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.88 +0.01 (0.17%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/03/2024
Time: BMO |
3/2024 | $0.09 | 0.00% |
Earnings Summary
For their last quarter, Amneal Pharmaceuticals (AMRX) reported earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.07 per share. This reflects a positive earnings surprise of 100.00%. Look out for AMRX's next earnings release on May 03, 2024. For the next earning release, we expect the company to report earnings of $0.09 per share, reflecting a year-over-year decrease of 25%.
Earnings History
Price & Consensus
Zacks News for AMRX
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
AMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services